— Know what they know.
Not Investment Advice
Also trades as: 0K16.L (LSE) · $vol 0M

EOLS NASDAQ

Evolus, Inc.
1W: -2.0% 1M: +24.3% 3M: +47.6% YTD: -4.0% 1Y: -35.2% 3Y: -33.6% 5Y: -28.8%
$6.09
-0.36 (-5.58%)
 
Weekly Expected Move ±9.3%
$5 $6 $6 $7 $8
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 63 · $401.1M mcap · 50M float · 2.26% daily turnover · Short 28% of daily vol

Balance Sheet Trends

Total Assets
$226M -2.9% ▼
5Y CAGR: +1.6%
Total Liabilities
$249M +9.7% ▲
5Y CAGR: -2.5%
Shareholders Equity
-$23M -518.4% ▼
Cash & Investments
$54M -38.1% ▼
5Y CAGR: -12.9%
Total Debt
$155M +19.2% ▲
5Y CAGR: +2.3%
Net Debt
$101M +135.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$146M$54M$63M$87M$54M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$146M$54M$63M$87M$54M
Net Receivables$15M$22M$31M$48M$55M
Inventory$2M$19M$11M$12M$27M
Other Current Assets$11M$2M$2M$1M$7M
Total Current Assets$179M$101M$112M$151M$143M
Property, Plant & Equip.$4M$5M$8M$10M$0
Goodwill & Intangibles$72M$70M$68M$70M$69M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$3M$3M$409K$858K$14M
Total Non-Current Assets$79M$77M$77M$81M$83M
Total Assets$257M$178M$189M$233M$226M
— Liabilities —
Accounts Payable$6M$9M$4M$9M$23M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$8M$9M$11M$14M$0
Other Current Liabilities$0$0$18M$0$49M
Total Current Liabilities$58M$47M$48M$63M$75M
Long-Term Debt$71M$72M$120M$122M$146M
Other Non-Current Liab.$44M$40M$36M$36M$21M
Total Non-Current Liabilities$118M$113M$161M$164M$174M
Total Liabilities$176M$159M$210M$227M$249M
— Equity —
Common Stock$1K$1K$1K$1K$1K
Retained Earnings-$423M-$497M-$559M-$609M-$661M
Accumulated OCI$0-$337K-$427K-$905K-$156K
Total Stockholders Equity$82M$18M-$21M$6M-$23M
Total Liabilities & Equity$257M$178M$189M$233M$226M
— Key Metrics —
Total Debt$75M$74M$127M$130M$155M
Net Debt-$72M$21M$64M$43M$101M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms